Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma.
Hajime YasudaNaoko KagaHikari TakaTomonori OchiaiTomohito YamanaYoshiki MiuraMidori IshiiMakoto SasakiJun AndoMiki AndoPublished in: Cancer chemotherapy and pharmacology (2023)
PV therapy may be a relatively safe treatment method for DLBCL patients on HD.